Read our latest articles

Over the past three years, supply chain issues and drug shortages have become regular headlines and major stressors for pharma companies, HCPs, and patients. While pharma companies want to avoid this kind of press, there is also a great financial risk in overproducing medications that could expire before they are prescribed. Accurate sales forecasts help companies know how much of a drug is likely to be prescribed so they can prepare for what is ahead, as well as ensuring that every patient gets the treatment needed without excessive surplus. Predictive analytics tools can utilize artificial intelligence (AI) to help companies make better forecasts1, among other benefits, such as more optimized marketing.

‍TORONTO - Today we announced that ODAIA has been listed as a Sample Vendor in the Gartner Hype Cycle for Life Science Commercial Operations, 2023 in the Sales Performance Management in LS category. Addressing the need for modern technology tools tailored for the pharmaceutical sales process, ODAIA’s automation and predictive analytics capabilities empower pharma sales representatives to make robust, data-driven decisions thanks to near-real-time visualizations and insights.

Sales reps in the pharmaceutical industry face many challenges in their day-to-day. They are constantly on the go, managing large territories and struggling to get face-to-face meetings with busy doctors. In order to get these conversations, reps put in extra preparatory work that can make days even longer and face higher pressure on time-limited calls. It's no wonder that pharma sales reps experience a high level of burnout. New tools that leverage the power of artificial intelligence (AI) show promising results for reducing burnout and improving work-life balance for these hardworking individuals.

Over the past year, Artificial Intelligence (AI) has become more prevalent than ever in mainstream media. New AI tools with the ability to take a simple prompt and generate visual art or writing samples have given rise to speculation about what AI is capable of and what it means for the future of many industries. Unsurprisingly, many people express concern about whether or not AI-driven automation could replace human workers. However, in most cases, AI’s best use is making people more efficient at their jobs, not replacing them altogether. This can especially be true in the realm of pharmaceutical sales.

ODAIA, developers of MAPTUAL, an AI-powered commercial insights SaaS platform for pharmaceutical companies, today announced several key personnel additions as it strengthens its executive and sales/business development teams on the heels of its $25M Series B round. Rebecca Skvorc joined ODAIA as Chief Financial Officer, while Jim Diefenbach was named SVP of Sales and Mike Goulart as Sr. Director, Business Acceleration.

With funding, ODAIA to fuel expansion and support the rapid growth of its AI-powered solutions that help pharma companies put life changing therapies in the hands of patients faster

As the pharmaceutical industry becomes more competitive, it is increasingly vital for companies to find ways to improve operational efficiencies. Many pharma sales teams rely on a customer relationship management (CRM) platform and multiple pharma data repositories as reference points to inform their day-to-day operations. However, gleaning meaningful insights from these disjointed and often out-of-date systems can be challenging for even the most tech-savvy sales reps. The next generation of predictive analytics tools enables sales teams to harness the power of data when prospecting, qualifying, and engaging customers. 

The pandemic has accelerated the use and implementation of digital technologies globally. So much so that in a survey performed by Verdict, 35% of respondents out of 482 polled, opined that the pandemic has accelerated digital transformation in the pharmaceutical industry by five years.

The prospective partnership will help commercial pharma teams achieve their business goals by delivering personalized, relevant HCP messaging at scale